PV pharm branch, vendor, cage 0U9U0
Ended Awarded Last action
- Contract number
- SPE2D826F09F1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $59,249
Award facts
- Contract value 100% obligated
- $59,249.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency Medical Supply Chain awarded a $59,249.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 28, 2026, with completion scheduled for January 29, 2026. This non-set-aside delivery order is being performed in Conshohocken, Pennsylvania, and represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc. (doing business as AmerisourceBergen), which serves as the parent contracting entity. The company is a major pharmaceutical distributor providing critical medical products to military healthcare systems, the Defense Health Agency, U.S. Coast Guard, and other federal healthcare programs.
AmerisourceBergen's pharmaceutical supply portfolio includes brand-name and generic medications, vaccines, specialty drugs, and medical supplies across multiple therapeutic domains such as diabetes management, neurological treatments, pain management, and antibiotics. The company's consistent receipt of competitively awarded delivery orders demonstrates its capability to meet federal procurement requirements and efficiently fulfill government contracts for essential pharmaceutical and medical commodities required by military treatment facilities and veterans' healthcare programs. The DLA Medical Supply Chain is planning to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning AmerisourceBergen as a key strategic supplier for federal medical procurement needs.
Quick answers
Who was awarded contract SPE2D826F09F1?
SPE2D826F09F1 was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on January 28, 2026.
How much is contract SPE2D826F09F1 worth?
The government has obligated $59,249 on SPE2D826F09F1.
Is contract SPE2D826F09F1 an order under another contract?
Yes. SPE2D826F09F1 is a delivery order under SPE2DX22D0069, an indefinite delivery contract.
Was contract SPE2D826F09F1 competed?
The extent of competition for SPE2D826F09F1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award